Park National Corp OH Buys 216 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Park National Corp OH boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,796 shares of the company’s stock after acquiring an additional 216 shares during the period. Park National Corp OH’s holdings in GE HealthCare Technologies were worth $297,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. LGT Financial Advisors LLC increased its position in shares of GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after buying an additional 251 shares during the period. Fred Alger Management LLC acquired a new stake in GE HealthCare Technologies during the 2nd quarter worth about $26,000. Capital Performance Advisors LLP bought a new position in shares of GE HealthCare Technologies in the 3rd quarter worth about $26,000. Ashton Thomas Securities LLC acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at about $26,000. Finally, Elkhorn Partners Limited Partnership bought a new stake in shares of GE HealthCare Technologies during the 2nd quarter valued at about $31,000. Institutional investors own 82.06% of the company’s stock.

Insider Activity at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.27% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of brokerages have weighed in on GEHC. Stifel Nicolaus lifted their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a report on Monday, September 30th. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their price objective for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. Evercore ISI raised their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price objective for the company from $95.00 to $103.00 in a report on Wednesday. Finally, BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Wednesday, September 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $96.00.

GE HealthCare Technologies Trading Up 3.5 %

NASDAQ GEHC opened at $86.26 on Thursday. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The firm has a market capitalization of $39.41 billion, a P/E ratio of 23.70, a PEG ratio of 2.90 and a beta of 1.11. The business has a fifty day simple moving average of $82.31 and a 200 day simple moving average of $84.04. GE HealthCare Technologies Inc. has a 12 month low of $71.31 and a 12 month high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. During the same quarter in the prior year, the company posted $0.99 earnings per share. The firm’s revenue for the quarter was up .9% on a year-over-year basis. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Tuesday, January 14th. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. GE HealthCare Technologies’s dividend payout ratio is currently 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.